Company
Vaxcyte, Inc.
Vaxcyte, Inc. has 1 drug tracked on RxWires: 1 in Phase 3.
Pipeline
| Drug | Phase | Indication |
|---|---|---|
| 31-valent pneumococcal conjugate vaccine | Phase 3 | Pneumococcal Disease |
Latest
No recent events.
Follow Vaxcyte, Inc. on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.